Correctly distinguishing between look-alike tumors found in the brain during surgery can guide critical decisions in real ...

BLRX READ THE FULL BLRX RESEARCH REPORT In a highly anticipated event, BioLineRx Ltd. (NASDAQ:BLRX) announced a deal to ...

Glioblastoma, a particularly aggressive form of brain cancer, could see its resistance to treatments weakened by a simple ...

Innovate GBM, a 501(c)(3) nonprofit dedicated to transforming the landscape of brain tumor research, investment, and ...

BN001, a signal seeking Phase II randomized trial, indicated that photon radiation dose intensification (75 Gy) did not demonstrate improvement in overall survival (OS) for patients with newly ...

Glioblastoma (GBM), an aggressive form of cancer that grows in the brain or spinal cord, occurs at an incidence rate of about 3/100,000 persons in the United States. Effective treatments remain ...

A new study, led by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of ...

Rogue DNA rings known as ecDNA may hold the key to cracking glioblastoma’s deadly resilience. Emerging before tumors even ...

A team led by scientists at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and ...

Michael Bolton’s battle with glioblastoma has brought renewed attention to one of the most complex, deadly and treatment-resistant cancers. The singer, 72, told People he was diagnosed in December ...

On A Path Toward Realizing Its Clinical Trial Plans For Rare Pediatric Cancer Therapy. <li /> Texas-based clinical-stage biotechnology company Lantern Pharma Inc. is developing a number of clinical ...